Aurora Cannabis Q2 Revenue Growth Slows Amid Decline in Consumer Sales

viernes, 7 de noviembre de 2025, 1:42 am ET1 min de lectura
ACB--

Aurora Cannabis reported Q2 medical cannabis revenue growth slowing, with consumer sales declining. Despite this, the company's overall revenue increased 2% YoY to CAD 55.6 million. Aurora's net loss widened to CAD 137.3 million from CAD 90.3 million in the same period last year. The company's gross margin decreased to 53% from 63% in Q2 2021.

Aurora Cannabis Q2 Revenue Growth Slows Amid Decline in Consumer Sales

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios